Digital Therapeutics Field Is Fast On The Rise, Ehave Is Advancing Research In Psychedelics And ADHD Therapy

The upcoming Benzinga Deal Room, set to take place on June 30, 2020, connects well-vetted cannabis companies with accredited investors looking to place capital. Among the line-up is Ehave.

Ehave, Inc. (OTCMKTS:EHVVF) is a provider of digital therapeutics, delivering evidence-based therapeutic interventions to patients. 

Ehave’s main focus is on helping improve the standard care in therapeutics to prevent/treat brain disorders or diseases through the use of digital therapeutics, psychedelics, and other therapies. An …

Full story available on Benzinga.com

More Digital Therapeutics Field Is Fast On The Rise, Ehave Is Advancing Research In Psychedelics And ADHD Therapy